| 1 | of the isebtt newsletter | | | | | | | 14 | 2.22% |
| 2 | the isebtt newsletter has | | | | | | | 14 | 2.22% |
| 3 | isebtt newsletter has been | | | | | | | 13 | 2.06% |
| 4 | issue of the isebtt | | | | | | | 13 | 2.06% |
| 5 | 2024 issue of the | | | | | | | 10 | 1.58% |
| 6 | newsletter has been published | | | | | | | 7 | 1.11% |
| 7 | 2023 issue of the | | | | | | | 4 | 0.63% |
| 8 | january 2024 issue of | | | | | | | 4 | 0.63% |
| 9 | march 2024 issue of | | | | | | | 4 | 0.63% |
| 10 | february 2024 issue of | | | | | | | 4 | 0.63% |
| 11 | delft role of the | | | | | | | 4 | 0.63% |
| 12 | december 2023 issue of | | | | | | | 4 | 0.63% |
| 13 | role of the cellular | | | | | | | 4 | 0.63% |
| 14 | position at tu delft | | | | | | | 3 | 0.47% |
| 15 | phd position at tu | | | | | | | 3 | 0.47% |
| 16 | at tu delft role | | | | | | | 3 | 0.47% |
| 17 | tu delft role of | | | | | | | 3 | 0.47% |
| 18 | of the cellular cytoskeleton | | | | | | | 3 | 0.47% |
| 19 | the cellular cytoskeleton in | | | | | | | 3 | 0.47% |
| 20 | electroporation and cargo translocation | | | | | | | 3 | 0.47% |
| 21 | and cargo translocation rocket | | | | | | | 3 | 0.47% |
| 22 | vaccine targeting telomerase for | | | | | | | 2 | 0.32% |
| 23 | biocybernetics is looking for | | | | | | | 2 | 0.32% |
| 24 | of biocybernetics is looking | | | | | | | 2 | 0.32% |
| 25 | society for electroporationbased technologies | | | | | | | 2 | 0.32% |
| 26 | is looking for a | | | | | | | 2 | 0.32% |
| 27 | looking for a young | | | | | | | 2 | 0.32% |
| 28 | for a young researcher | | | | | | | 2 | 0.32% |
| 29 | for electroporationbased technologies and | | | | | | | 2 | 0.32% |
| 30 | standard operating procedures for | | | | | | | 2 | 0.32% |
| 31 | for treatment of canine | | | | | | | 2 | 0.32% |
| 32 | targeting telomerase for treatment | | | | | | | 2 | 0.32% |
| 33 | treatment of canine lymphoma | | | | | | | 2 | 0.32% |
| 34 | membrane electroporation and cargo | | | | | | | 2 | 0.32% |
| 35 | tumours and skin metastases | | | | | | | 2 | 0.32% |
| 36 | cytoskeleton in membrane electroporation | | | | | | | 2 | 0.32% |
| 37 | cellular cytoskeleton in membrane | | | | | | | 2 | 0.32% |
| 38 | official journal of the | | | | | | | 2 | 0.32% |
| 39 | laboratory of biocybernetics is | | | | | | | 2 | 0.32% |
| 40 | telomerase for treatment of | | | | | | | 2 | 0.32% |